Dave Lashmet’s Venture #73: The Pentagon’s Chipmaker – Is It Legit?

Dave Lashmet recently found a small, up-and-coming chipmaker that’s 100% U.S.-owned. It has a barrier to entry that competitors can’t easily match…

And he believes it’s virtually guaranteed to receive hundreds of millions of dollars – or more – from Congress as it pours $52 billion into the chip industry.

If you act now, you’ll get all the specifics about this opportunity… plus a full year of Dave’s Venture Technology research… at 55% off the regular price.

The controversial economist and former Presidential adviser, Larry Lindsey, just warned of a coming currency war with China.

He said:

“The stated goal of the Communist Party of China is to become the world superpower – and that’s bad news for us.”

But this week, the story takes a dramatic new turn, and presents you with an unusual investing opportunity.

One that has nothing to do with gold, silver, cryptocurrencies, or Chinese stocks.

It’s part of a brewing crisis that’s already impacting you in ways you’ve probably overlooked…

Which is why it’s so important for you to understand exactly what’s at stake.

Our colleagues at Stansberry Research just broke this story and we advise you to take take time to check it out today.

Tune in right here to see what they’ve uncovered.

Photo of author
Mark Winkel is a U.S.-based author and entrepreneur who lives in the greater New York City area. He studied marketing at the University of Washington and started actively investing in 2017. His approach to the markets blends fundamental research with technical chart analysis, and he concentrates on both swing trades and longer-term positions. Mark's mission is to share tips and strategies at Steady Income to help everyday people make smarter money moves. Mark is all about making finance easier to understand — whether you're just starting out or have been trading for years.


You may also like these posts...

Joel Litman High Alpha Strategic Acquirers in the Health Care Space

Joel Litman High Alpha Strategic Acquirers in the Health Care Space

Get Joel Litman and Doc Eifrig’s list of favorite health care stocks. These are companies with ample cash flow and the financial muscle to make smart acquisitions as 1 in 3 U.S. companies collide into a Wall of Debt.
exponential tech investor review by real user

Exponential Tech Investor Review – Is Jeff Brown’s Newsletter Good?

Explore our in-depth review of Jeff Brown’s Exponential Tech Investor. Is it a legit investment service or hype? Uncover the truth about its claims and performance.